Moyens de défense des bactéries

Revue Medicale de la Suisse Romande

Volumn 120, Issue 8, 2000, Pages 641-650

  Moreillon, Philippe ^a  

^a LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT;

ANTIBIOTIC RESISTANCE; BACTERIAL PHENOMENA AND FUNCTIONS; CELL MEMBRANE PERMEABILITY; DRUG EFFECT; HUMAN; PATIENT SELECTION; PHYSIOLOGY; R FACTOR; REVIEW;

ANTI-BACTERIAL AGENTS; BACTERIAL PHYSIOLOGY; CELL MEMBRANE PERMEABILITY; DRUG RESISTANCE, MICROBIAL; HUMANS; PATIENT SELECTION; R FACTORS;

EID: 0034243556     PISSN: 00353655     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (55)

1. Florey H.W., Cairns H.: Penicillin in war wounds. A report from the Mediterranean. Lancet, (ii): 742-745, 1943.
2. Kilbourne E.D.: History of influenza. In: Kilbourne E.D., ed. Influenza. New York, Plenum Medical, 1-22, 1987.
3. Tomasz A.: Multiple-antibiotic-resistant pathogenic bacteria. N. Engl. J. Med., 330: 1247-1251, 1994.
4. Hiramatsu K., Hanaki H., Ino T., Yabuta K., Oguri T., Tenover F.C.: Methicillin-resistant Staphylococcus aureus clinical strain with reduced vancomycin susceptibility. J. Antimicrob. Chemother., 40: 135-136, 1997.
5. Hancock R.E.W.: Role of porins in outer membrane permeability. J. Bacteriol., 169: 929-933, 1987.
6. Nikaido H, Vaara M.: Molecular basis of outer membrane permeability. Microbiol. Rev., 49: 1-32, 1985.
7. Anwar H., Dasgupta M.K., Costerton J.W.: Testing the susceptibility of bacteria in biofilms to antibacterial agents. Antimicrob. Agents Chemother., 34: 2043-2046, 1990.
8. Nikaido H.: Prevention of drug access to bacterial targets: permeability barriers and active efflux. Science, 264: 382-388, 1994.
9. Hooper D.C., Wolfson J.S., Bozza M.A., Ng E.Y.: Genetics and regulation of outer membrane protein expression by quinolone resistance Loci nfxB, nfxC, and cfxB. Antimicrob. Agents Chemother., 36: 1151-1154, 1992.
10. Livermore D.M.: Interplay of impermeability and chromosomal β-lactamase activity in imipenem-resistant Pseudomonas aeruginosa. Antimicrob. Agents Chemother., 36: 2046-2048, 1992.
11. Mates S.M., Patel L., Kaback H.R., Miller M.H.: Membrane potential in anaerobically growing Staphylococcus aureus and its relationship to gentamicin uptake. Antimicrob. Agents Chemother., 23: 526-530, 1983.
12. Miller M.H., Edberg S.C., Mandel L.J., Behar C.F., Steigbigel N.H.: Gentamicin uptake in wild-type and aminoglycoside-resistant small-colony mutants of Staphylococcus aureus. Antimicrob. Agents Chemother., 18: 722-729, 1980.
13. Tait-Kamradt A., Clancy J., Cronan M., Dib-Hajj F, Wondrack L., Yuan W., Sutcliffe J.: mefE is necessary for the erythromycin-resistant M phenotype in Streptococcus pneumoniae. Antimicrob. Agents Chemother., 41: 2251-2255, 1997.
14. Higgins C.F.: ABC transporters: from microorganisms to man. Ann. Rev. Cell. Biol., 8:67-113, 1992.
15. Kaatz G.W., Seo S.M., Ruble C.A.: Efflux-mediated fluoroquinolone resistance in Staphylococcus aureus. Antimicrob. Agents Chemother., 37: 1086-1094, 1993.
16. Ross J.I., Eady E.A., Cove J.H., Cunliffe W.J., Baumberg S., Wootton J.C.: Inducible erythromycin resistance in staphylococci is encoded by a member of the ATP-binding transport super-gene family. Mol. Microbiol., 4: 1207-1214, 1990.
17. Clancy J., Petitpas J., Dib-Hajj F., Yuan W., Cronan M., Kamath A.V., Bergeron J., Retsema J.A.: Molecular cloning and functional analysis of a novel macrolide-resistance determinant, mefA, from Streptococcus pyogenes. Mol. Microbiol., 22: 867-879, 1996.
18. Perrez-Trallero E., Urbieta M., Montes M., Ayestaran I., Marimon M.: Emergence of Streptococcus pyogenes strains resistant to erythromycin in Gipuzka, Spain. Eur. J. Clin. Microbiol. Infect. Dis., 16: 25-31, 1998.
19. Widdowson C.A., Klugman P.: Emergence of the M phenotype of erythromycin-resistant pneumococci in South Africa. Emerg. Infect. Dis., 4: 277-281, 1998.
20. Cohen S.P., Yan W., Levy S.B.: A multidrug resistance regulatory chromosomal locus is widespread among enteric bacteria. J. Infect. Dis., 168: 484-488, 1993..
21. Sanglard D., Ischer F., Monod M., Bille J.: Susceptibilities of Candida albicans multitransporter mutants to various antifungal agents and other metabolic inhibitors. Antimicrob. Agents Chemother., 40: 2300-2305, 1996.
22. Spratt B.G.: Resistance to antibiotics mediated by target alterations. Science, 264: 388-393, 1994.
23. Hancock R.E.W.: Aminoglycoside uptake and mode of action with special reference to streptomycin and gentamicin. J. Antimicrob. Chemother., 8: 249-276, 1981.
24. Wehrli W.: Rifampicin: mechanisms of action and resistance. Rev. Infect. Dis., 5 (suppl 3): S407-S412, 1983.
25. Cambau E., Gutmann L.: Mechanisms of resistance to quinolones. Drugs, 45 (Suppl.3): 15-23, 1993.
26. Voss A., Milatovic D., Wallrauch-Schwarz C., Rosdahl V.T., Braveny I.: Methicillin-resistant Staphylococcus aureus in Europe. Eur. J. Clin. Microbiol. Infect. Dis., 13: 50-55, 1994.
27. Cometta A., Calandra T., Bille J., Glauser M.P.: Escherichia coli resistant to fluoroquinolones in patients with cancer and neutropenia. N. Engl. J. Med., 330: 240, 1994.
28. Chambers H.F., Hartman B.J., Tomasz A.: Increased amounts of a novel penicillin binding protein in a strain of methicillin-resistant Staphylococcus aureus. J. Clin. Invest., 76: 325-331, 1985.
29. Matthews P., Tomasz A.: Insertional inactivation of the mec gene in a transposon mutant of a methicillin-resistant clinical isolate of Staphylococcus aureus. Antimicrob. Agents Chemother., 34: 1777-1779, 1990.
30. Couto I., De Lencastre H., Severina E., Kloos W., Webster J.A., Hubner R.J., Santos Sanches I., Tomasz A.: Ubiquitous presence of a mecA homologue in natural isolates of Staphylococcus sciuri. Microb. Drug Resistance, 2: 377-391, 1996.
31. Leclercq R., Courvalin P.: Bacterial resistance to macrolide, lincosamide, and streptogramin antibiotics by target modification. Antimicrob. Agents Chemother., 35: 1267-1272, 1991.
32. Speer B.S., Shoemaker N.B., Salyers A.A.: Bacterial resistance to tetracycline: mechanisms, transfer and clinical significance. Clin. Microbiol. Rev., 5: 387-399, 1992.
33. Ghuysen J.M.: Serine beta-lactamases and penicillin-binding proteins. Annu. Rev. Microbiol., 45: 37-67, 1991.
34. Philippon A., Labia R., Jacoby G.: Extended-spectrum β-lactamases. Antimicrob. Agents Chemother., 33: 1131-1136, 1989.
35. Davies J.: Inactivation of antibiotics and the dissemination of resistance genes. Science, 264: 375-382, 1994.
36. Leclercq R., Carlier C., Duval J., Courvalin P.: Plasmid-mediated resistance to lincomycin by inactivation in Staphylococcus haemolyticus. Antimicrob. Agents Chemother., 28: 421-424, 1985.
37. LeGoffic F., Capmau M.L., Abbe J., Cerceau C., Dublanchet A., Duval J.: Plasmid mediated pristinamycin resistance: PH1A, a pristinamycin 1A hydrolase. Ann. Microbiol. (Paris),128: 471-474, 1977.
38. Speer B.S., Salyers A.A.: Novel aerobic tetracycline resistance gene that chemically modifies tetracycline. J. Bacteriol., 171: 148-153, 1989.
39. Arthur M., Courvalin P.: Genetics and mechanisms of glycopeptide resistance in enterococci. Antimicrob. Agents Chemother., 37: 1563-1571, 1993.
40. Evers S., Quintiliani Jr R., Courvalin P.: Genetics of glycopeptide resistance in enterococci. Microb. Drug Resistance, 2: 2219-223, 1996.
41. Noble W.C., Virani Z., Cree R.G.A.: Co-transfer of vancomycin and other resistance genes from Enterococcus faecal is NCTC 12201 to Staphylococcus aureus. FEMS Microbiol. Lett., 93: 195-198, 1992.
42. Poyart C., Pierre C., Quesne G., Pron B., Berche P., Trieu-Cuot P.: Emergence of vancomycin resistance in the genus Streptococcus: characterization of a VanB transferable determinant in Streptococcus bovis. Antimicrob. Agents Chemother., 41: 24-29, 1997.
43. Sieradyki K., Tomasz A.: Inhibition of cell wall turn over and autolysis by vancomycin in a highly vancomycin-resistant mutant of Staphylococcus aureus. J. Bacteriol. 179: 2557-2566, 1997.
44. Piddock L.J.: New quinolones and gram positive bacteria. Antimicrob. Agents Chemother., 38: 163-169, 1994.
45. Stein G.E.: Pharmacokinetics and pharmacodynamics of newer fluoroquinolones. Clin. Infect. Dis., 23 (suppl 1): S19-S24, 1996.
46. Entenza J.M., Vouillamoz J., Glauser M.P., Moreillon P.: Levofloxacin versus ciprofloxacin, flucloxacillin, or vancomycin for treatment of experimental endocarditis due to methicillin-susceptible or -resistant Staphylococcus aureus. Antimicrob. Agents Chemother., 41: 1662-1667, 1997.
47. Entenza J.M., Vouillamoz J., Glauser M.P., Moreillon P.: Efficacy of trovafloxacin in the treatment of experimental staphylococcal and streptococcal endocarditis. Antimicrob. Agents Chemother., 43: 77-84, 1999.
48. Kelly J.A., Dideberg O., Charlier P., Wery J.P., Libert M., Moews P.C., Knox J.R., Duez C., Fraipont Cl., Joris B., Dusart J., Frere J.M., Ghuysen J.M.: On the origin of bacterial resistance to penicillin: comparison of a beta-lactamase and a penicillin target. Science, 231: 1429-1431, 1986.
49. Kent J.H.: The epidemiology of multidrug-resistant tuberculosis in the United States. Med. Clin. North Am., 77: 1391-1409, 1993.
50. Kuntz I.D.: Structure-based strategies for drug design and discovery. Science, 257: 1078-1082, 1992.
51. Franciolli M., Bille J., Glauser M.P., Moreillon P.: β-lactam resistance mechanisms of methicillin-resistant Staphylococcus aureus. J. Infect. Dis., 163: 514-523, 1991.
52. Que Yok-Ai, Entenza J.M., Francioli P., Moreillon P.: The impact of penicillinase on cefamandole treatment of experimental endocarditis due to methicillin-resistant Staphylococcus aureus. J. Infect. Dis., 177: 146-154, 1988.
53. Moreillon P., Tomasz A.: Penicillin resistance and defective lysis in clinical isolates of pneumococci: evidence for two kinds of antibiotic pressure operating in the clinical environment. J. Infect. Dis., 157:1150-1157, 1988.
54. Seppala H., Klaukka T., Vuopio-Varkilla J., Muotiala A., Helenius H., Lager K., Huovinen P.: The effect of changes in the consumption of macrolide antibiotics on erythromycin resistance in group streptococci in Finland. N. Engl. J. Med., 337: 441-446, 1997.
55. Moreillon P.: La résistance bactérienne aux antibiotiques. Schweiz. Med. Wschr., 125: 1151-1161, 1995.